Phase II Trial of Daily Oral Etoposide in Advanced Non-Small Cell Lung Cancer

Abstracts/Posters/Presentations:

• Saxman S, Logie K, Stephens D, Workman F, Scullin D, Loehrer PJ: Phase II Trial of Daily Oral Etoposide in Patients with Surgically Unresectable Non Small Cell Lung Cancer LUN88-6. Proc Am Soc Clin Oncol 9:142, l990.

Manuscripts/Articles:

• Saxman S, Loehrer PJ Sr, Logie K, Stephens D, Workman F, Scullin D, Einhorn LH, Ansari R. Phase II trial of daily oral etoposide in patients with advanced non-small cell lung cancer. Invest New Drugs. 1991 Aug;9(3):253-6. See abstract.